tiprankstipranks
Trending News
More News >
Azitra Inc (AZTR)
:AZTR
US Market

Azitra Inc (AZTR) Price & Analysis

Compare
161 Followers

AZTR Stock Chart & Stats


Bulls Say, Bears Say

Bulls Say
Clinical TrialsFocus remains on lead program ATR-12 in Netherton syndrome, which dosed the first patient in its P1b study, with initial data expected soon.
Regulatory ApprovalsATR-04 has fast track designation, indicating a streamlined development process to potentially bring the therapy to market sooner.
Bears Say
Financial PerformanceFactoring in dilution associated with the two recent financings lowers the 12-month price target to $2.00, from $3.00.

Financials

Options Prices

Currently, No data available
---

Ownership Overview

5.80%0.21%0.41%93.59%
0.21%
Mutual Funds
0.41% Other Institutional Investors
93.59% Public Companies and Individual Investors

AZTR FAQ

What was Azitra Inc’s price range in the past 12 months?
Azitra Inc lowest stock price was $0.23 and its highest was $12.00 in the past 12 months.
    What is Azitra Inc’s market cap?
    Currently, no data Available
    When is Azitra Inc’s upcoming earnings report date?
    Azitra Inc’s upcoming earnings report date is Aug 18, 2025 which is in 66 days.
      How were Azitra Inc’s earnings last quarter?
      Azitra Inc released its earnings results on May 13, 2025. The company reported -$0.23 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.23.
        Is Azitra Inc overvalued?
        According to Wall Street analysts Azitra Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Azitra Inc pay dividends?
          Azitra Inc does not currently pay dividends.
          What is Azitra Inc’s EPS estimate?
          Azitra Inc’s EPS estimate is -0.21.
            How many shares outstanding does Azitra Inc have?
            Azitra Inc has 17,226,355 shares outstanding.
              What happened to Azitra Inc’s price movement after its last earnings report?
              Azitra Inc reported an EPS of -$0.23 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Azitra Inc?
                Currently, no hedge funds are holding shares in AZTR

                Company Description

                Azitra Inc

                Azitra Inc (AZTR) is a biotechnology company focused on harnessing the power of the microbiome to develop innovative therapeutic solutions. The company specializes in developing microbiome-based products and treatments aimed at addressing various skin conditions and diseases. Through its proprietary platform, Azitra combines scientific research and clinical expertise to create targeted therapies that improve skin health and treat dermatological disorders.
                Similar Stocks
                Company
                Price & Change
                Follow
                Biodexa Pharmaceuticals
                Salarius Pharmaceuticals
                Processa Pharmaceuticals
                GRI Bio
                Protagenic Therapeutics
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis